Hygeia Healthcare Warns of Sharp 2025 Profit Drop but Reports Stronger Cash Flow and Lower Debt

The latest update is out from Hygeia Healthcare Holdings Co., Ltd. ( (HK:6078) ).

Hygeia Healthcare issued a profit warning for 2025, flagging an expected 9–10% decline in revenue to about RMB4.0–4.05 billion and a steep 66–76% drop in net profit to roughly RMB140–200 million, largely driven by a one-off goodwill impairment related to Etern Group, industry and macroeconomic headwinds, and start-up costs plus higher depreciation from newly opened hospitals. Non-IFRS adjusted net profit is projected to fall 19–25% year-on-year, yet operating cash flow is expected to rise 33–41% to around RMB940 million–1.0 billion, bank debt has been reduced by about RMB340 million, and capital expenditure is trending down as the last major self-built hospital nears completion, underscoring a shift from heavy investment to cash generation and efficiency that could support improved financial resilience and shareholder returns despite short-term earnings pressure.

The most recent analyst rating on (HK:6078) stock is a Hold with a HK$15.00 price target. To see the full list of analyst forecasts on Hygeia Healthcare Holdings Co., Ltd. stock, see the HK:6078 Stock Forecast page.

More about Hygeia Healthcare Holdings Co., Ltd.

Hygeia Healthcare Holdings Co., Ltd. is a China-focused oncology healthcare services group that operates a network of specialized hospitals, with a strategic emphasis on cancer diagnosis and treatment and related medical services. The Group has been expanding through self-built and acquired hospitals and is increasingly integrating AI technologies and refined management to enhance operational efficiency and patient care in the oncology segment.

Average Trading Volume: 3,573,257

Technical Sentiment Signal: Sell

Current Market Cap: HK$7.97B

Find detailed analytics on 6078 stock on TipRanks’ Stock Analysis page.